[Genetic basis of Cushing's disease in children and targeted therapeutic future perspectives]

Probl Endokrinol (Mosk). 2020 Dec 11;66(6):39-49. doi: 10.14341/probl12676.
[Article in Russian]

Abstract

Cushing's disease (CD) is a multisystem disorder of a cortisol excess caused by ACTH -secreting pituitary tumor (corticotropinoma). CD in children is due to somatic or germline mutations with the late onset causing multiple endocrine tumors. If not treated, hypercortisolism leads to severe decrease in quality of life and life-threating conditions. The first-line treatment for CD is pituitary surgery, which might be followed by complications and relapse with necessity of additional surgery or initiations of second-line treatment. Recent studies of molecular basis of corticotropinoma development made it possible to employ medical therapy in CD. Understanding of corticotropinoma etiology and pathogenesis is an important part of education for pediatric endocrinologists since we need to keep in mind possibility of multisystem disorder in case of CD in children and because medical therapy might gain more important role for CD treatment in future.The most actual genetic aspects of corticotroph adenomas growth and the medical treatment opportunities are present in this review.

Publication types

  • Review

MeSH terms

  • ACTH-Secreting Pituitary Adenoma*
  • Adenoma*
  • Child
  • Humans
  • Neoplasm Recurrence, Local
  • Pituitary ACTH Hypersecretion* / genetics
  • Quality of Life